Mitsuru Ishizuka
Overview
Explore the profile of Mitsuru Ishizuka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishizuka M, Shibuya N, Hachiya H, Nishi Y, Kono T, Takayanagi M, et al.
Eur J Surg Oncol
. 2024 Jul;
50(10):108538.
PMID: 39053042
Objective: To investigate whether robotic surgery (RS) decreases the risk of circumferential resection margin (CRM) positivity compared with conventional laparoscopic surgery (LS) in patients with rectal cancer (RC) undergoing mesorectal...
2.
Shimizu T, Aoki T, Ishizuka M, Sakamoto K, Beppu T, Honda G, et al.
Int J Surg
. 2024 Jun;
110(10):6691-6701.
PMID: 38869986
Introduction: Two-stage hepatectomy (TSH) enables patients to undergo surgery for colorectal liver metastasis (CRLM), which one-stage hepatectomy cannot remove. Although the outcome of TSH has been reported, there is no...
3.
Matsumoto T, Shiraki T, Niki M, Sato S, Tanaka G, Shimizu T, et al.
Eur J Surg Oncol
. 2024 Apr;
50(6):108356.
PMID: 38685177
Background: Because repeat hepatectomy for recurrent hepatocellular carcinoma is a potentially invasive procedure, it is necessary to identify patients who truly benefit from repeat hepatectomy. Albumin-bilirubin grading has been reported...
4.
Ishizuka M, Shibuya N, Hachiya H, Nishi Y, Takayanagi M, Fujita J, et al.
J Gastrointest Surg
. 2024 Apr;
28(4):548-558.
PMID: 38583909
Background: Although several recent meta-analyses have investigated the clinical influence of the addition of lateral lymph node dissection (LLND) on oncologic outcomes in patients with mid-low rectal cancer (RC) undergoing...
5.
Matsumoto T, Shiraki T, Tanaka G, Yamaguchi T, Park K, Mori S, et al.
World J Surg
. 2024 Mar;
48(5):1219-1230.
PMID: 38468392
Background: Despite the accumulating evidence regarding the oncological differences between nonalcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC) and viral infection-related HCC, the short- and long-term outcomes of surgical resection...
6.
Ihara K, Nakamura T, Takayanagi M, Fujita J, Maeda Y, Nishi Y, et al.
J Anus Rectum Colon
. 2024 Feb;
8(1):18-23.
PMID: 38313747
Objectives: Stoma outlet obstruction (SOO) occurs with an incidence of approximately 40% after proctocolectomy for Ulcerative colitis (UC) with diverting ileostomy. This study aimed to identify the risk factors for...
7.
Suda K, Shimizu T, Ishizuka M, Miyashita S, Niki M, Shibuya N, et al.
Surg Endosc
. 2023 Dec;
38(2):1114.
PMID: 38117358
No abstract available.
8.
Ishizuka M, Shibuya N, Hachiya H, Nishi Y, Fujita J, Ihara K, et al.
Surg Oncol
. 2023 Jul;
50:101972.
PMID: 37481917
Objective: To explore the influence of the no-touch isolation technique (NTIT) on oncologic outcomes for patients with colon cancer (CC) undergoing curative surgery. Background: Although several studies have investigated this...
9.
Miyashita S, Shimizu T, Ishizuka M, Niki M, Nishi Y, Shibuya N, et al.
Anticancer Res
. 2023 Apr;
43(5):2219-2225.
PMID: 37097679
Background/aim: Fluoropyrimidine therapy or oxaliplatin combination therapy is recommended for patients with stage III colorectal cancer as adjuvant chemotherapy (AC). However, the criterion for selecting these regimens is still unclear...
10.
Kaga K, Yamanishi T, Kamasako T, Kaga M, Fuse M, Ishizuka M
Cureus
. 2023 Feb;
15(1):e34166.
PMID: 36843763
Background Tibial nerve stimulation therapy is a treatment option for an overactive bladder. A surface electrode called a Silver Spike Point® electrode, which does not directly puncture the skin as...